Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed
Open Access
- 17 June 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (25) , eaba4024
Abstract
Autologous tumor cell–based vaccines (ATVs) are emerging as a transformable approach for personalized immunotherapy, but their therapeutic efficacy remains unsatisfying in patients with cancer. Here, we design a photodynamic therapy (PDT)–motivated ATV (P-ATV) in Fmoc-KCRGDK–phenylboronic acid (FK-PBA) hydrogel, which mobilizes local immune activation to inhibit relapse of postoperative tumors. The FK-PBA targeting overexpressed sialic acid on tumor cells can enable on-demand gelation in residue tumor areas and maintain continuous vaccination in surgical bed. Unlike neoantigen-based vaccine or adoptive cell therapy that takes several months to prepare, P-ATV can be easily manufactured within a few days and efficiently boost neoepitope-specific CD8+ T cells to activate personalized immunotherapy. This simple and powerful approach of engineered ATVs provides an alternative strategy for personalized immunotherapy and is readily transformable to various kinds of cell-based antigens to inhibit the relapse of postoperative tumors.Keywords
Funding Information
- National Natural Science Foundation of China (81690265, 81803444, 81521005)
- National Natural Science Foundation of China (81903548)
- Chinese Academy of Sciences (XDA12050307)
- Chinese Academy of Sciences (2019283)
- Science and Technology Commission of Shanghai Municipality (19YF1457300)
This publication has 42 references indexed in Scilit:
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cellsScience, 2015
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacyNature Biotechnology, 2014
- Summary of bi-shRNAfurin/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the LiverOncology, 2014
- Structure-based programming of lymph-node targeting in molecular vaccinesNature, 2014
- Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid TumorsJournal of the American Chemical Society, 2013
- A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to BedsideClinical Cancer Research, 2013
- Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical TrialWorld Neurosurgery, 2012
- Hypochlorous Acid: A Natural Adjuvant That Facilitates Antigen Processing, Cross-Priming, and the Induction of Adaptive ImmunityThe Journal of Immunology, 2009
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Cancer immunotherapy: moving beyond current vaccinesNature Medicine, 2004